This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Gelecekteki Büyüme

We currently don't have sufficient analyst coverage to forecast growth and revenue for Clinical Laserthermia Systems.

56.9%

Kazanç büyüme oranı

50.0%

EPS büyüme oranı

Medical Equipment kazanç büyümesi	30.4%
Gelir büyüme oranı	56.5%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	24 Feb 2023

Güncelleme yok

Güncelleme yok

Kazanç ve Gelir Büyüme Tahminleri

OM:CLS UR B - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2025	115	-2	N/A	N/A	1
12/31/2024	44	-45	-48	-45	1
12/31/2023	17	-70	-70	-67	1
3/31/2023	6	-78	-71	-68	N/A
12/31/2022	6	-71	-69	-68	N/A
9/30/2022	3	-81	-81	-81	N/A
6/30/2022	2	-63	-66	-66	N/A
3/31/2022	2	-68	-71	-71	N/A
12/31/2021	2	-64	-67	-66	N/A
9/30/2021	1	-60	-63	-63	N/A
6/30/2021	2	-57	-55	-55	N/A
3/31/2021	2	-47	-41	-41	N/A
12/31/2020	1	-58	-56	-55	N/A
9/30/2020	1	-58	-54	-53	N/A
6/30/2020	2	-57	-54	-54	N/A
3/31/2020	6	-54	-52	-52	N/A
12/31/2019	6	-43	-39	-39	N/A
9/30/2019	6	-38	-37	-36	N/A
6/30/2019	5	-37	-35	-34	N/A
3/31/2019	1	-41	-44	-43	N/A
12/31/2018	8	-33	-41	-39	N/A
9/30/2018	10	-28	-33	-31	N/A
6/30/2018	11	-24	-33	-31	N/A
3/31/2018	12	-15	-29	-24	N/A
12/31/2017	8	-21	-29	-24	N/A
9/30/2017	8	-22	-34	-29	N/A
6/30/2017	8	-26	-28	-24	N/A
3/31/2017	6	-27	-24	-23	N/A
12/31/2016	4	-27	N/A	-20	N/A
9/30/2016	1	-27	N/A	-19	N/A
6/30/2016	0	-23	N/A	-22	N/A
3/31/2016	0	-20	N/A	-17	N/A
12/31/2015	N/A	-17	N/A	-19	N/A
9/30/2015	0	-21	N/A	-21	N/A
6/30/2015	0	-20	N/A	-20	N/A
3/31/2015	0	-20	N/A	-19	N/A
12/31/2014	N/A	-18	N/A	-16	N/A
9/30/2014	0	-16	N/A	-18	N/A
6/30/2014	N/A	-16	N/A	-18	N/A
3/31/2014	N/A	-17	N/A	-17	N/A
12/31/2013	N/A	-18	N/A	-18	N/A
9/30/2013	0	-16	N/A	-13	N/A
6/30/2013	N/A	-15	N/A	-12	N/A
3/31/2013	0	-13	N/A	-11	N/A
12/31/2012	N/A	-13	N/A	-12	N/A
9/30/2012	0	-11	N/A	-10	N/A

Kazançlar ve Tasarruf Oranları: CLS UR B is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: CLS UR B is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: CLS UR B is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: CLS UR B's revenue (56.5% per year) is forecast to grow faster than the Swedish market (5.5% per year).

Yüksek Büyüme Geliri: CLS UR B's revenue (56.5% per year) is forecast to grow faster than 20% per year.

Gelecekteki ROE: Insufficient data to determine if CLS UR B's Return on Equity is forecast to be high in 3 years time